Citicoline in Ischemic Stroke, a Randomized Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 800 participants.
Also called NCT06210646
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 800 participants
- Sponsor
- Registry
-
NCT06210646
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Egypt
- Registry status
- Completed
Technical summary
Registry record NCT06210646. Randomized; double masking; primary purpose treatment. Start 2022-12-29 (actual); primary completion 2024-06-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Citicoline in Ischemic Stroke, a Randomized Trial
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Citicoline 2000
- Intervention (Drug)
- citocoline 1000
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06210646- Content hash
39ae10866a4ef266d406b3ff6fcfafab80e3db7e10272c0259944943c91a1f89